Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Aptose Biosciences is a clinical-stage biotechnology company. The company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates that exert activity as stand-alone agents and that enhance the activities of other anticancer agents without causing overlapping toxicities.